Whilst this classification is based on gene expression profiling, these equate to a simplified immunohistochemical tumor phenotype dependent on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation marker Antigen Kiel 67 (Ki67) (Table 1). This evidence concerns the gene PGR and neoplasm.